Watchlist Price Alert

Esperion Therapeutics Inc... (ESPR)

NASDAQ: ESPR · Real-Time Price · USD

0.80

-0.09 (-10.39%)

At close: May 09, 2025, 3:59 PM

0.80

0.24%

After-hours: May 09, 2025, 05:43 PM EDT

Esperion Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	332.31M	116.33M	75.47M	78.45M	227.55M	148.36M	184.47M	n/a	n/a
Cost of Revenue	68.6M	43.27M	26.97M	14.22M	2.39M	175.61M	265K	258K	252K
Gross Profit	263.71M	73.07M	48.51M	64.23M	225.16M	-27.25M	184.21M	-258K	-252K
Operating Income	54.4M	-155.56M	-179.5M	-226.73M	-121.4M	-93.1M	-204.59M	-168.98M	-76.15M
Interest Income	n/a	n/a	2.6M	112K	600K	4M	n/a	n/a	n/a
Pretax Income	-51.74M	-209.25M	-233.66M	-269.11M	-143.55M	-97.17M	-201.81M	-166.99M	-74.98M
Net Income	-51.74M	-209.25M	-287.82M	-318.82M	-166.19M	-109.02M	-201.81M	-166.99M	-74.98M
Selling & General & Admin	163.07M	142.52M	109.08M	184.99M	199.62M	65.85M	33.1M	21.38M	18.28M
Research & Development	46.24M	86.11M	118.93M	105.97M	146.94M	175.61M	171.49M	147.6M	57.87M
Other Expenses	n/a	n/a	2.65M	3.98M	515K	4.06M	2.77M	2.19M	1.55M
Operating Expenses	209.31M	228.63M	228.01M	290.96M	346.55M	241.47M	204.59M	168.98M	76.15M
Interest Expense	59.25M	58.98M	56.81M	46.35M	22.67M	8.12M	100K	198K	376K
Selling & Marketing Expenses	n/a	15.6M	11.3M	13.7M	19.3M	n/a	n/a	n/a	n/a
Cost & Expenses	277.91M	271.9M	254.98M	305.18M	348.94M	241.47M	204.59M	168.98M	76.15M
Income Tax Expense	n/a	n/a	54.16M	49.72M	22.64M	11.86M	2.88M	2.13M	1.67M
Shares Outstanding (Basic)	187.18M	103.11M	66.41M	28.9M	27.47M	27.09M	26.75M	23.93M	22.54M
Shares Outstanding (Diluted)	187.18M	103.11M	66.41M	28.9M	27.47M	27.09M	26.75M	23.93M	22.54M
EPS (Basic)	-0.28	-2.03	-4.33	-11.03	-6.05	-4.02	-7.54	-6.98	-3.33
EPS (Diluted)	-0.28	-2.03	-4.33	-11.03	-6.05	-4.02	-7.54	-6.98	-3.33
EBITDA	7.57M	-150.11M	-176.35M	-222.14M	-120.33M	-88.73M	-204.32M	-166.53M	-74.35M
EBIT	7.51M	-150.27M	-176.85M	-222.75M	-120.88M	-89.05M	-204.59M	-166.79M	-74.6M
Depreciation & Amortization	63K	164K	500K	612K	547K	319K	265K	258K	252K